We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$27.3M
Cap. Flow
-$34.7M
Cap. Flow %
-23.28%
Top 10 Hldgs %
25.17%
Holding
298
New
63
Increased
40
Reduced
80
Closed
82

Top Buys

Rank Stock Value
1
ABVX
Abivax
ABVX
+$2.73M
2
PFE icon
Pfizer
PFE
+$2.42M
3
ARGX icon
argenx
ARGX
+$2.33M
4
VYNE icon
VYNE Therapeutics
VYNE
+$2.08M
5
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$1.95M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$3.38M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.95M
3
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$2.75M
4
TSVT
2seventy bio
TSVT
+$2.58M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 59.47%
2 Real Estate 11.94%
3 Financials 4.93%
4 Consumer Discretionary 2.41%
5 Industrials 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSVT
276
DELISTED
2seventy bio
TSVT
– –
-657,500
Closed -$2.58M
URI icon
277
CALL
United Rentals
URI
$65.5B
– –
-310
Closed -$138K
UTHR icon
278
United Therapeutics
UTHR
$22.7B
– –
-9,000
Closed -$2.03M
VKTX icon
279
Viking Therapeutics
VKTX
$4.31B
– –
-60,000
Closed -$664K
VLO icon
280
Valero Energy
VLO
$91.9B
– –
-1,724
Closed -$244K
VRDN icon
281
Viridian Therapeutics
VRDN
$1.99B
– –
-80,000
Closed -$1.23M
XOM icon
282
ExxonMobil
XOM
$611B
– –
-2,390
Closed -$281K
ZBRA icon
283
Zebra Technologies
ZBRA
$12.7B
– –
-2,500
Closed -$591K
MRO
284
DELISTED
Marathon Oil Corporation
MRO
– –
-8,936
Closed -$239K
PETQ
285
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
-52,000
Closed -$1.02M
MOR
286
DELISTED
MorphoSys AG American Depositary Shares
MOR
– –
-185,000
Closed -$1.24M
DCPH
287
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-132,000
Closed -$1.68M
PXD
288
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-531
Closed -$122K
PNT
289
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-67,400
Closed -$450K
HZNP
290
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-25,500
Closed -$2.95M
8 9 10 11
12

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, AlphaCentric Advisors held 298 positions worth $149M, down 16% from $176M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

AlphaCentric Advisors withdrew a net $34.7M in Q4 2023, closing 82 positions and reducing 80 holdings. Its most notable exit was Neurocrine Biosciences, an estimated $3.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 62% a quarter earlier, followed by Real Estate and Financials.

Against the trend, AlphaCentric Advisors opened a new position in Abivax worth $2.86M.

  • AlphaCentric Advisors's largest Q4 2023 buy was Abivax: 267,500 shares worth $2.86M.
  • AlphaCentric Advisors added most to argenx in Q4 2023, an estimated $2.33M increase.
  • AlphaCentric Advisors's biggest Q4 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $2.75M.
  • AlphaCentric Advisors fully exited Neurocrine Biosciences in Q4 2023, selling an estimated $3.38M.
  • AlphaCentric Advisors's ten largest holdings make up 25% of its $149M portfolio in Q4 2023.
  • AlphaCentric Advisors opened 63 new positions and closed 82 in Q4 2023.
  • AlphaCentric Advisors's portfolio value fell 16% quarter-over-quarter to $149M.

Based on AlphaCentric Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.